Hyperandrogenemia is neceesary but not sufficient for polycystic ovary syndrome

Fertility and Sterility

Volumn 80, Issue 2, 2003, Pages 262-263

  Dunaif, Andrea ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; INSULIN;

ANDROGEN BLOOD LEVEL; CLINICAL FEATURE; DISEASE MARKER; GENE EXPRESSION REGULATION; GENETIC TRAIT; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; BLOOD; FEMALE; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

FEMALE; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; SIGNAL TRANSDUCTION;

EID: 0041563929     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00732-5     Document Type: Note

References (11)

1. Weiss D.J., Charles M.A., Dunaif A., Prior D.E., Lillioja S., Knowler W.C., et al. Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism. 43:1994;803-807.
2. Book C.B., Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 84:1999;3110-3116.
3. Ciaraldi T.P., Morales A.J., Hickman M.G., Odom-Ford R., Yen S.S., Olefsky J.M. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome. Metabolism. 47:1998;940-946.
4. Willis D., Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab. 80:1995;3788-3790.
5. Nestler J.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 83:1998;2001-2005.
6. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 79:1994;1158-1165.
7. Nelson V.L., Legro R.S., Strauss J.F., McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 13:1999;946-957.
8. Baillargeon J.-P., Jakubowicz D.J., Luorno M.J., Jakubowicz S., Nestler J.E., Effects of metformin and rosiglitazone, alone and in combination, in lean women with polycystic ovary syndrome and normal insulin sensitivity. 84th Annual Meeting of the Endocrine Society. San Francisco, CA .abstract OR 10-1.
9. Corbould A, Dunaif A. Enhanced insulin responsiveness of mitogen-activated protein kinases in cultured PCOS skeletal muscle. 84th Annual Meeting of the Endocrine Society. San Francisco, CA. abstract OR 33-6.
10. Legro R.S., Driscoll D., Strauss J.F., Fox J., Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 95:1998;14956-14960.
11. Legro R.S, Bentley-Lewis R., Driscoll A., Wang S., Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab. 87:2002;2128-2133.